Reply: A Proposition for the Use of Radioiodine in WDTC Management
- 21 January 2009
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 50 (2) , 329-330
- https://doi.org/10.2967/jnumed.108.057349
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid CarcinomaJournal of Nuclear Medicine, 2008
- Expanding Indications for Recombinant Human TSH in Thyroid CancerThyroid®, 2008
- Clinical Features and Therapeutic Implication of Papillary Thyroid MicrocarcinomaThyroid®, 2007
- Treatment of Micropapillary Carcinoma of the Thyroid: Where Do We Draw the Line?Thyroid®, 2007
- Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid CarcinomasJournal of Clinical Endocrinology & Metabolism, 2005
- Epidemiology of Thyroid Microcarcinoma Found in Autopsy Series Conducted in Areas of Different Iodine IntakeThyroid®, 2005
- Prognostic Scoring Systems in Patients with Follicular Thyroid Cancer: A Comparison of Different Staging Systems in Predicting the Patient OutcomeThyroid®, 2004
- Follicular thyroid carcinoma: Histology and prognosisCancer, 2004
- Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocalityCancer, 2003
- Papillary microcarcinoma of the thyroid glandBritish Journal of Surgery, 1996